<DOC>
	<DOCNO>NCT02345330</DOCNO>
	<brief_summary>This study ass safety effectiveness intratumoral plasmid interleukin-12 DNA injection ( pIL-12 ) electroporation ( EP ) treatment-refractory metastatic unresectable squamous cell carcinoma head neck ( HNSCC ) . Intratumoral pIL-12 EP gene therapy approach directly induce pro-inflammatory response within tumor initiate and/or enhance anti-tumor immunity .</brief_summary>
	<brief_title>Trial pIL-12 Electroporation Squamous Cell Carcinoma Head Neck ( IL12HNSCC )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Interleukin-12</mesh_term>
	<criteria>Histological cytological diagnosis SCC head neck AJCC Stage III , IVA IVB amenable surgical resection locoregional radiation therapy curative intent . Patients must measurable disease define RECIST v1.1 Patients must platinumrefractory disease defined disease progression within 12 month platinumbased chemoradiation curative intent disease progression platinumbased chemotherapy absence radiation Age â‰¥ 18 year old ECOG performance status 02 Life expectancy least 3 month Adequate organ function Female patient childbearing potential negative pregnancy test within 14 day prior start study drug Able give inform consent Prior therapy IL12 prior gene therapy Concurrent ongoing administration systemic therapy ( e.g . chemotherapy ) , radiation therapy Evidence significant active infection ( e.g. , pneumonia , cellulitis , wound abscess , etc . ) time study entry Pregnant breastfeed woman exclude Patients electronic pacemaker defibrillator exclude Significant disease uncontrolled disease , i.e . cardiovascular renal , hepatic , endocrine , metabolic , neurologic ; significant disease would limit patient ability participate study determine investigator medical monitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>